Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY80.99 CNY
Change Today -5.28 / -6.12%
Volume 17.7M
000538 On Other Exchanges
As of 3:00 AM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

yunnan baiyao group co ltd-a (000538) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/24/15 - CNY89.31
52 Week Low
07/14/14 - CNY47.10
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for YUNNAN BAIYAO GROUP CO LTD-A (000538)

Related News

No related news articles were found.

yunnan baiyao group co ltd-a (000538) Related Businessweek News

No Related Businessweek News Found

yunnan baiyao group co ltd-a (000538) Details

Yunnan Baiyao Group Co., Ltd. manufactures and sells Chinese pharmaceutical products in China and internationally. The company provides Yunnan Baiyao series of products, including powders, capsules, plasters, woundplasts, and aerosols for activating blood circulation, dispersing blood stasis, reducing swelling, and relieving pain, as well as to treat traumatic injuries, rheumatic paralysis, pains in bones, muscle aches, and cold injuries. It also offers phytobiological medicines in the forms of oral liquids, tablets, powders, flower-leave granules, and capsules; and health products consisting of toothpastes, itching-relieving and smoothing essential skin cares, shower and foot bath effervescent tablets, shoe disinfectant and deodorize aerosols, and first aid kits. In addition, the company provides medicines, such as paracetamol, aminophenazone, caffeine, and chlorphenamine maleate tablets, as well as oxytetracycline tablets and norfloxacin capsules. Yunnan Baiyao Group Co., Ltd. is based in Kunming, China.

yunnan baiyao group co ltd-a (000538) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

yunnan baiyao group co ltd-a (000538) Key Developments

Yunnan Baiyao Group Co., Ltd. Approves Amendments to Articles of Association

Yunnan Baiyao Group Co., Ltd. announced that the annual general meeting held on May 28, 2015, approved amendments to the company's articles of association.

Yunnan Baiyao Group Co., Ltd. Approves Profit Distribution Plan of 2014

Yunnan Baiyao Group Co., Ltd. at its annual general meeting of 2014 held on May 28, 2015, the share holders approved 2014 profit distribution plan of cash dividend (tax included) of CNY 5.00000000 per 10 shares.

Yunnan Baiyao Group Co., Ltd. to Report Q1, 2015 Results on Apr 30, 2015

Yunnan Baiyao Group Co., Ltd. announced that they will report Q1, 2015 results on Apr 30, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000538:CH CNY80.99 CNY -5.28

000538 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000538.
View Industry Companies

Industry Analysis


Industry Average

Valuation 000538 Industry Range
Price/Earnings 34.9x
Price/Sales 4.6x
Price/Book 7.6x
Price/Cash Flow 35.0x
TEV/Sales 4.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact YUNNAN BAIYAO GROUP CO LTD-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at